Webinar: PSCIの紹介、AMRの脅威と製薬企業の責任 PSCI Intro, the Threat of AMR and Pharmaceutical Responsibility
About: This webinar is presented in Japanese.
Antimicrobial Resistance (AMR) is a critical global challenge that poses serious threats to healthcare systems worldwide. This webinar provides a clear overview of the fundamentals of AMR and outline how the pharmaceutical industry should respond to this pressing issue.
It introduces the Antibiotic Manufacturing Standard developed by the AMR Industry Alliance and highlight emerging certification schemes designed to ensure responsible practices across the industry. In addition, key initiatives led by the SHIONOGI Group will be presented, illustrating the path toward sustainable healthcare.
This session offers a valuable opportunity to deepen your understanding of AMR and explore practical approaches to addressing this global concern.
Speakers
- Kozo Ohashi, EHS Management Group Member, Corporate Governance Department, Shionogi
Kozo Ohashi has 3 years of experience in EHS management at SHIONOGI, leading responsible manufacturing initiatives for antimicrobial resistance (AMR). He is a member of the AMR Industry Alliance Manufacturing Working Group and previously spent 18 years in clinical development, contributing to new drug research, including antibiotics. - Wenjia Xu, Associate Director, Global Safety and Environment, MSD, PSCI capability committee co-lead
Wenjia is an EHS professional with 20 years of experience in chemical and pharmaceutical industries, currently at MSD Global Safety and Environment. He specializes in EHS due diligence for suppliers and projects and has strong expertise in PSCI principles through 8 years of audit and capability-building work.
The slides used in the webinar can be accessed here.